Janux Therapeutics, Inc. (JANX)
17.84
+0.02
(+0.11%)
USD |
NASDAQ |
Nov 04, 14:48
Janux Therapeutics Price to Book Value : 1.174 for Nov. 4, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 1.173 |
| November 02, 2026 | 1.149 |
| October 30, 2026 | 1.150 |
| October 29, 2026 | 1.174 |
| October 28, 2026 | 1.188 |
| October 27, 2026 | 1.136 |
| October 26, 2026 | 1.098 |
| October 23, 2026 | 1.096 |
| October 22, 2026 | 1.123 |
| October 21, 2026 | 1.114 |
| October 20, 2026 | 1.132 |
| October 19, 2026 | 1.102 |
| October 16, 2026 | 1.087 |
| October 15, 2026 | 1.14 |
| October 14, 2026 | 1.128 |
| October 13, 2026 | 1.131 |
| October 12, 2026 | 1.195 |
| October 09, 2026 | 1.210 |
| October 08, 2026 | 1.218 |
| October 07, 2026 | 1.180 |
| October 06, 2026 | 1.105 |
| October 05, 2026 | 1.089 |
| October 02, 2026 | 1.114 |
| October 01, 2026 | 1.116 |
| September 30, 2026 | 1.137 |
| Date | Value |
|---|---|
| September 29, 2026 | 1.116 |
| September 28, 2026 | 1.091 |
| September 25, 2026 | 1.073 |
| September 24, 2026 | 1.098 |
| September 23, 2026 | 1.087 |
| September 22, 2026 | 1.150 |
| September 21, 2026 | 1.120 |
| September 18, 2026 | 1.092 |
| September 17, 2026 | 1.110 |
| September 16, 2026 | 1.069 |
| September 15, 2026 | 1.082 |
| September 14, 2026 | 1.139 |
| September 11, 2026 | 1.126 |
| September 10, 2026 | 1.164 |
| September 09, 2026 | 1.272 |
| September 08, 2026 | 1.319 |
| September 04, 2026 | 1.332 |
| September 03, 2026 | 1.303 |
| September 02, 2026 | 1.297 |
| September 01, 2026 | 1.243 |
| August 31, 2026 | 1.199 |
| August 28, 2026 | 1.187 |
| August 27, 2026 | 1.236 |
| August 26, 2026 | 1.243 |
| August 25, 2026 | 1.230 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Iovance Biotherapeutics, Inc. | 5.360 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 22.05 |
| Anika Therapeutics, Inc. | 1.998 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 46.42 |
| Price | 17.84 |
| Earnings Yield | -9.21% |
| Market Cap | 1.090B |